| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr5:124264000-124271400 |
Weak transcription |
HSMM |
muscle
|
| 2 |
chr5:124269000-124271600 |
Weak transcription |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 3 |
chr5:124269000-124271600 |
Weak transcription |
HMEC |
breast
|
| 4 |
chr5:124269200-124271200 |
Weak transcription |
Right Atrium |
heart
|
| 5 |
chr5:124269200-124271600 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
| 6 |
chr5:124269200-124271600 |
Weak transcription |
NHEK |
skin
|
| 7 |
chr5:124269800-124272600 |
Enhancers |
Dnd41 |
blood
|
| 8 |
chr5:124270000-124272200 |
Enhancers |
Primary Natural Killer cells fromperipheralblood |
blood
|
| 9 |
chr5:124270400-124271200 |
Flanking Active TSS |
GM12878-XiMat |
blood
|
| 10 |
chr5:124270400-124272600 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
| 11 |
chr5:124270400-124276000 |
Weak transcription |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 12 |
chr5:124270600-124271800 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 13 |
chr5:124270800-124271800 |
Enhancers |
ES-I3 Cell Line |
embryonic stem cell
|
| 14 |
chr5:124270800-124272000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 15 |
chr5:124270800-124272200 |
Enhancers |
NH-A |
brain
|
| 16 |
chr5:124271000-124271200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
| 17 |
chr5:124271000-124271400 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
| 18 |
chr5:124271000-124272000 |
Enhancers |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
| 19 |
chr5:124271000-124272000 |
Enhancers |
K562 |
blood
|
| 20 |
chr5:124271000-124275800 |
Weak transcription |
ES-WA7 Cell Line |
embryonic stem cell
|
